Factors Involved in the Regulation of Type I Collagen Gene Expression: Implication in Fibrosis

Type I collagen, the major component of extracellular matrix in skin and other tissues, is a heterotrimer of two α1 and one α2 collagen polypeptides. The synthesis of both chains is highly regulated by different cytokines at the transcriptional level. Excessive synthesis and deposition of collagen in the dermal region causes thick and hard skin, a clinical manifestation of scleroderma. To better understand the causes of scleroderma or other tissue fibrosis, it is very Important to investigate the molecular mechanisms that cause upregulation of the Type I collagen synthesis in these tissues. Several cis-acting regulatory elements and trans-acting protein factors, which are involved in basal as well as cytokine-modulated Type I collagen gene expression, have been identified and characterized. Hypertranscription of Type I collagen in scleroderma skin fibroblasts may be due to abnormal activities of different positive or negative transcription factors In response to different abnormally induced signaling pathways. In this review, I discuss the present day understanding about the involvement of different factors in the regulation of basal as well as cytokine-modulated Type I collagen gene expression and its implication in scleroderma research.

[1]  A. Atfi,et al.  Tumor Necrosis Factor-α Inhibits Transforming Growth Factor-β /Smad Signaling in Human Dermal Fibroblasts via AP-1 Activation* , 2000, The Journal of Biological Chemistry.

[2]  J. Uitto,et al.  Tumor necrosis factor-alpha and interferon-gamma suppress the activation of human type I collagen gene expression by transforming growth factor-beta 1. Evidence for two distinct mechanisms of inhibition at the transcriptional and posttranscriptional levels. , 1990, The Journal of clinical investigation.

[3]  M. Sporn,et al.  A nuclear factor 1 binding site mediates the transcriptional activation of a type I collagen promoter by transforming growth factor-β , 1988, Cell.

[4]  L. Suen,et al.  Suppression of Type I Collagen Gene Expression by Prostaglandins in Fibroblasts Is Mediated at the Transcriptional Level Address Correspondence and Reprint Requests To , 2000 .

[5]  J. Varga,et al.  Inhibition of type I collagen mRNA expression independent of tryptophan depletion in interferon-gamma-treated human dermal fibroblasts. , 1995, The Journal of investigative dermatology.

[6]  A. Rivas-Estilla,et al.  Tumor necrosis factor α down‐regulates expression of the α1(I) collagen gene in rat hepatic stellate cells through a p20C/EBPβ‐ and C/EBPδ‐dependent mechanism , 2000 .

[7]  A Mazars,et al.  c-Jun interacts with the corepressor TG-interacting factor (TGIF) to suppress Smad2 transcriptional activity , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[8]  E. Leroy,et al.  Elevated expression of c-myc proto-oncogene in scleroderma fibroblasts. , 1988, Oncogene.

[9]  N. L. La Thangue,et al.  p300/CBP proteins: HATs for transcriptional bridges and scaffolds. , 2001, Journal of cell science.

[10]  C. Junien,et al.  Isolation and Characterization of the Human Fibrillar Collagen Genes a , 1985, Annals of the New York Academy of Sciences.

[11]  Michael D. Schneider,et al.  Transforming Growth Factor-β Receptor-associated Protein 1 Is a Smad4 Chaperone* , 2001, The Journal of Biological Chemistry.

[12]  A. Ghosh,et al.  Antagonistic regulation of type I collagen gene expression by interferon-gamma and transforming growth factor-beta. Integration at the level of p300/CBP transcriptional coactivators. , 2001, The Journal of biological chemistry.

[13]  H. Ihn,et al.  Transcriptional Regulation of the Human α2(I) Collagen Gene , 1996, The Journal of Biological Chemistry.

[14]  H. Ihn,et al.  Sp3 is a transcriptional activator of the human α2(I) collagen gene , 1997 .

[15]  A. Gabrielli,et al.  c-myb proto-oncogene is expressed by quiescent scleroderma fibroblasts and, unlike B-myb gene, does not correlate with proliferation. , 1996, The Journal of investigative dermatology.

[16]  P. Bornstein Regulation of expression of the alpha 1 (I) collagen gene: a critical appraisal of the role of the first intron. , 1996, Matrix biology : journal of the International Society for Matrix Biology.

[17]  B. Crombrugghe,et al.  Three different polypeptides are necessary for DNA binding of the mammalian heteromeric CCAAT binding factor. , 1992, The Journal of biological chemistry.

[18]  C. Feghali,et al.  Expression of c-myc, c-myb, and c-sis in fibroblasts from affected and unaffected skin of patients with systemic sclerosis. , 1993, Autoimmunity.

[19]  B. Smith,et al.  Methylation in the initiation region of the first exon suppresses collagen pro-alpha2(I) gene transcription. , 1998, Biochimica et biophysica acta.

[20]  D. Brenner,et al.  NF-I/Sp1 Switch Elements Regulate Collagen α1(I) Gene Expression , 1992 .

[21]  J. Wrana,et al.  Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF beta receptor for degradation. , 2000, Molecular cell.

[22]  G. Karsenty,et al.  Cbfa1 Contributes to the Osteoblast-specific Expression of type I collagen Genes* , 2001, The Journal of Biological Chemistry.

[23]  M. Trojanowska,et al.  Characterization of a GC-rich Region Containing Sp1 Binding Site(s) as a Constitutive Responsive Element of the α2(I) Collagen Gene in Human Fibroblasts (*) , 1995, The Journal of Biological Chemistry.

[24]  E. Bottinger,et al.  A mechanism of suppression of TGF–β/SMAD signaling by NF-κB/RelA , 2000, Genes & Development.

[25]  R. Ravazzolo,et al.  Purification and functional characterization of a DNA-binding protein that interacts with a negative element in the mouse alpha 1(I) collagen promoter. , 1991, Journal of Biological Chemistry.

[26]  P. Donahoe,et al.  Specific interaction of type I receptors of the TGF-beta family with the immunophilin FKBP-12. , 1994, Science.

[27]  J. Massagué,et al.  Inhibition of transforming growth factor-β/SMAD signalling by the interferon-γ/STAT pathway , 1999, Nature.

[28]  S. Sinha,et al.  The Transcriptional Activity of the CCAAT-binding Factor CBF Is Mediated by Two Distinct Activation Domains, One in the CBF-B Subunit and the Other in the CBF-C Subunit* , 1996, The Journal of Biological Chemistry.

[29]  W. Couser,et al.  SPARC Regulates the Expression of Collagen Type I and Transforming Growth Factor-β1 in Mesangial Cells* , 1999, The Journal of Biological Chemistry.

[30]  J. Seyer,et al.  Transcriptional mechanisms of type I collagen gene expression are differentially regulated by interleukin-1 beta, tumor necrosis factor alpha, and transforming growth factor beta in Ito cells. , 1992, Journal of Biological Chemistry.

[31]  T. Krieg,et al.  Regulation of collagen expression by interleukin-1 beta is dependent on donor age. , 1996, Acta dermato-venereologica.

[32]  M. Olive,et al.  Tumor Necrosis Factor Alpha Inhibits Type I Collagen Synthesis through Repressive CCAAT/Enhancer-Binding Proteins , 2000, Molecular and Cellular Biology.

[33]  J. Massagué,et al.  A Smad Transcriptional Corepressor , 1999, Cell.

[34]  J. Myers,et al.  Human proα1(I) collagen gene structure reveals evolutionary conservation of a pattern of introns and exons , 1984, Nature.

[35]  J. Ou,et al.  Synergistic Cooperation between Sp1 and Smad3/Smad4 Mediates Transforming Growth Factor β1 Stimulation of α2(I)-Collagen (COL1A2) Transcription* , 2000, The Journal of Biological Chemistry.

[36]  P. Dijke,et al.  Interaction between GC Box Binding Factors and Smad Proteins Modulates Cell Lineage-specific α2(I) Collagen Gene Transcription* , 2001, The Journal of Biological Chemistry.

[37]  T. Krieg,et al.  Pathogenesis of fibrosis: type 1 collagen and the skin , 1998, Journal of Molecular Medicine.

[38]  J. Massagué,et al.  A mechanism of repression of TGFbeta/ Smad signaling by oncogenic Ras. , 1999, Genes & development.

[39]  Harold L. Moses,et al.  STRAP and Smad7 Synergize in the Inhibition of Transforming Growth Factor β Signaling , 2000, Molecular and Cellular Biology.

[40]  R. Bashey,et al.  Regulation of connective tissue synthesis in systemic sclerosis. , 1995, International reviews of immunology.

[41]  Anping Chen,et al.  UV Irradiation Activates JNK and Increases αI(I) Collagen Gene Expression in Rat Hepatic Stellate Cells* , 1999, The Journal of Biological Chemistry.

[42]  R. Derynck,et al.  TGF‐β‐induced repression of CBFA1 by Smad3 decreases cbfa1 and osteocalcin expression and inhibits osteoblast differentiation , 2001, The EMBO journal.

[43]  K. Tamaki,et al.  Increased phosphorylation of transcription factor Sp1 in scleroderma fibroblasts: association with increased expression of the type I collagen gene. , 2000, Arthritis and rheumatism.

[44]  C. Hartl,et al.  Direct demonstration of transcriptional activation of collagen gene expression in systemic sclerosis fibroblasts: insensitivity to TGF beta 1 stimulation. , 1992, Biochemical and biophysical research communications.

[45]  A. Roberts,et al.  A novel smad nuclear interacting protein, SNIP1, suppresses p300-dependent TGF-beta signal transduction. , 2000, Genes & development.

[46]  S. J. Chen,et al.  Modulation of human alpha1(I) procollagen gene activity by interaction with Sp1 and Sp3 transcription factors in vitro. , 1998, Gene.

[47]  M. Parker,et al.  Demethylation of the type I procollagen genes in transformed fibroblasts treated with 5-azacytidine. , 1984, Biochemical and biophysical research communications.

[48]  Y. Fujii‐Kuriyama,et al.  Two regulatory proteins that bind to the basic transcription element (BTE), a GC box sequence in the promoter region of the rat P‐4501A1 gene. , 1992, The EMBO journal.

[49]  R. Derynck,et al.  Regulation of Smad signalling by protein associations and signalling crosstalk. , 1999, Trends in cell biology.

[50]  Jiahuai Han,et al.  Activation of Extracellular Signal-regulated Kinase 1/2 Inhibits Type I Collagen Expression by Human Skin Fibroblasts* , 2000, The Journal of Biological Chemistry.

[51]  J. Gambee,et al.  Phosphorylation of p300 at Serine 89 by Protein Kinase C* , 2000, The Journal of Biological Chemistry.

[52]  R. Raghow,et al.  The role of extracellular matrix in postinflammatory wound healing and fibrosis , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[53]  A. Ghosh,et al.  Smad-dependent stimulation of type I collagen gene expression in human skin fibroblasts by TGF-β involves functional cooperation with p300/CBP transcriptional coactivators , 2000, Oncogene.

[54]  K. Miyazono,et al.  Characterization of the Interaction of FKBP12 with the Transforming Growth Factor-β Type I Receptor in Vivo* , 1996, The Journal of Biological Chemistry.

[55]  H. Nakajima,et al.  Interaction between Smad anchor for receptor activation and Smad3 is not essential for TGF-beta/Smad3-mediated signaling. , 2001, Biochemical and biophysical research communications.

[56]  S. Jimenez,et al.  Transcriptional activation of the alpha 1(I) procollagen gene in systemic sclerosis dermal fibroblasts. Role of intronic sequences. , 1996, Arthritis and rheumatism.

[57]  R. Serra Transforming Growth Factor beta (TGFβ) , 2002 .

[58]  S. Jimenez,et al.  Identification of elements in the promoter region of the alpha1(I) procollagen gene involved in its up-regulated expression in systemic sclerosis. , 1998, Arthritis and rheumatism.

[59]  P. Bornstein,et al.  A highly conserved intronic sequence is involved in transcriptional regulation of the alpha 1(I) collagen gene. , 1990, Cell regulation.

[60]  P. Donahoe,et al.  The Immunophilin FKBP12 Functions as a Common Inhibitor of the TGFβ Family Type I Receptors , 1996, Cell.

[61]  J. Uitto,et al.  Cytokine modulation of extracellular matrix gene expression: relevance to fibrotic skin diseases. , 2000, Journal of dermatological science.

[62]  A. Gabrielli,et al.  C-myb, but not B-myb, upregulates type I collagen gene expression in human fibroblasts. , 1999, The Journal of investigative dermatology.

[63]  E. Vuorio,et al.  Increased type I collagen mRNA levels in cultured scleroderma fibroblasts. , 1984, Biochimica et biophysica acta.

[64]  J. Seyer,et al.  Modulation of fibroblast functions by interleukin 1: increased steady- state accumulation of type I procollagen messenger RNAs and stimulation of other functions but not chemotaxis by human recombinant interleukin 1 alpha and beta , 1988, The Journal of cell biology.

[65]  Y. Fujii‐Kuriyama,et al.  Analysis of functional domains of a GC box-binding protein, BTEB. , 1995, Journal of biochemistry.

[66]  F Verrecchia,et al.  Blocking sp1 transcription factor broadly inhibits extracellular matrix gene expression in vitro and in vivo: implications for the treatment of tissue fibrosis. , 2001, The Journal of investigative dermatology.

[67]  B. Peterkofsky,et al.  Species differences in cis‐elements of the Proα1(I) procollagen promoter and their binding proteins , 1999, Journal of cellular biochemistry.

[68]  E. Mezey,et al.  CCAAT/enhancer binding protein beta mediates the activation of the murine alpha1(I) collagen promoter by acetaldehyde. , 2000, Archives of biochemistry and biophysics.

[69]  D. Clark,et al.  Transforming growth factor-beta (TGF-beta). , 1998, The international journal of biochemistry & cell biology.

[70]  P. P. Hu,et al.  Molecular Mechanisms of Transforming Growth Factor-β Signaling , 1998 .

[71]  D. Brenner,et al.  NF-kappaB inhibits expression of the alpha1(I) collagen gene. , 1999, DNA and cell biology.

[72]  J. Heino,et al.  Interleukin-1 increases collagen production and mRNA levels in cultured skin fibroblasts. , 1987, Biochimica et biophysica acta.

[73]  D. Brigstock,et al.  Connective tissue growth factor: what's in a name? , 2000, Molecular genetics and metabolism.

[74]  Peter F. Johnson,et al.  Insulin Suppresses Transactivation by CAAT/Enhancer-binding Proteins β (C/EBPβ) , 2001, The Journal of Biological Chemistry.

[75]  Liliana Attisano,et al.  SARA, a FYVE Domain Protein that Recruits Smad2 to the TGFβ Receptor , 1998, Cell.

[76]  R. W. Scott,et al.  Inhibition of tumor-cell-mediated extracellular matrix destruction by a fibroblast proteinase inhibitor, protease nexin I. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[77]  T. Wright,et al.  Identification of multiple, differentially expressed messenger RNAs in dermal fibroblasts from patients with systemic sclerosis. , 1999, Arthritis and rheumatism.

[78]  H. Lodish,et al.  Role of transforming growth factor beta in human disease. , 2000, The New England journal of medicine.

[79]  Wei Hu,et al.  Sp1 Is Required for the Early Response of α2(I) Collagen to Transforming Growth Factor-β1* , 1997, The Journal of Biological Chemistry.

[80]  M. Parker,et al.  Regulation of collagen I gene expression by ras , 1992, Molecular and cellular biology.

[81]  S. J. Chen,et al.  Stimulation of type I collagen transcription in human skin fibroblasts by TGF-beta: involvement of Smad 3. , 1999, The Journal of investigative dermatology.

[82]  G. Karsenty,et al.  c-Krox, a transcriptional regulator of type I collagen gene expression, is preferentially expressed in skin. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[83]  M. Karin,et al.  Signal transduction by tumor necrosis factor and its relatives. , 2001, Trends in cell biology.

[84]  Serhiy Souchelnytskyi,et al.  Regulation of Smad signaling by protein kinase C , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[85]  S. Hubchak,et al.  TGF-beta1 activates MAP kinase in human mesangial cells: a possible role in collagen expression. , 1999, Kidney international.

[86]  Jeffrey B. Kopp,et al.  TGF- and fibrosis , 1999 .

[87]  Tomoki Chiba,et al.  Smurf1 Interacts with Transforming Growth Factor-β Type I Receptor through Smad7 and Induces Receptor Degradation* , 2001, The Journal of Biological Chemistry.

[88]  P. Byers,et al.  Collagens: building blocks at the end of the development line , 2000, Clinical genetics.

[89]  Raymond Dalgleish,et al.  The human type I collagen mutation database , 1997, Nucleic Acids Res..

[90]  S. Jimenez,et al.  Regulation of human lung fibroblast alpha 1(I) procollagen gene expression by tumor necrosis factor alpha, interleukin-1 beta, and prostaglandin E2. , 1993, The Journal of biological chemistry.

[91]  M. Parker,et al.  Regional chromosome mapping of human collagen genes alpha 2(I) and alpha 1(I) (COLIA2 and COLIA1) , 2004, Human Genetics.

[92]  M L Chu,et al.  Organization of the human pro-alpha 2(I) collagen gene. , 1987, The Journal of biological chemistry.

[93]  M. Nugent,et al.  Basic fibroblast growth factor-induced decrease in type I collagen gene transcription is mediated by B-myb. , 1998, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[94]  J. Korn,et al.  A potential role for protease nexin 1 overexpression in the pathogenesis of scleroderma. , 1999, The Journal of clinical investigation.

[95]  M. Parker,et al.  Loss of type I procollagen gene expression in SV40-transformed human fibroblasts is accompanied by hypermethylation of these genes. , 1982, Nucleic acids research.

[96]  S. J. Chen,et al.  Modulation of endogenous Smad expression in normal skin fibroblasts by transforming growth factor-beta. , 2000, Experimental cell research.

[97]  S. Maity,et al.  Recombinant rat CBF-C, the third subunit of CBF/NFY, allows formation of a protein-DNA complex with CBF-A and CBF-B and with yeast HAP2 and HAP3. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[98]  G. Karsenty,et al.  Selective activation of transcription by a novel CCAAT binding factor. , 1988, Science.

[99]  S. Jimenez,et al.  CCAAT binding transcription factor binds and regulates human COL1A1 promoter activity in human dermal fibroblasts: demonstration of increased binding in systemic sclerosis fibroblasts. , 2000, Arthritis and rheumatism.

[100]  J. Seyer,et al.  Transcriptional Mechanisms of Type I Collagen Gene Expression Are Differentially Regulated by Interleukin-1 / ? , Tumor Necrosis Factor a , and Transforming Growth Factor fí in Ito Cells , 2003 .

[101]  R. Ravazzolo,et al.  A fibroblast-specific factor binds to an upstream negative control element in the promoter of the mouse alpha 1(I) collagen gene. , 1991, The Journal of biological chemistry.

[102]  R. Derynck,et al.  A WD-domain protein that is associated with and phosphorylated by the type II TGF-β receptor , 1995, Nature.

[103]  G. Franzoso,et al.  Structure, regulation and function of NF-kappa B. , 1994, Annual review of cell biology.

[104]  H. Moses,et al.  Interdependent SMAD and JNK Signaling in Transforming Growth Factor-β-mediated Transcription* , 1999, The Journal of Biological Chemistry.

[105]  S. Krane,et al.  Interleukin 1 suppresses expression of cartilage-specific types II and IX collagens and increases types I and III collagens in human chondrocytes. , 1988, The Journal of clinical investigation.

[106]  M. Buck,et al.  LAP (NF-IL6) transactivates the collagen alpha 1(I) gene from a 5' regulatory region. , 1994, The Journal of clinical investigation.

[107]  J. Varga,et al.  Interaction of Smad3 with a proximal smad‐binding element of the human α2(I) procollagen gene promoter required for transcriptional activation by TGF‐β , 2000 .

[108]  J. Wrana,et al.  The MAD-Related Protein Smad7 Associates with the TGFβ Receptor and Functions as an Antagonist of TGFβ Signaling , 1997, Cell.

[109]  A. Rivas-Estilla,et al.  Tumor necrosis factor alpha down-regulates expression of the alpha1(I) collagen gene in rat hepatic stellate cells through a p20C/EBPbeta- and C/EBPdelta-dependent mechanism. , 2000, Hepatology.

[110]  Qiang Zhou,et al.  The Ski oncoprotein interacts with the Smad proteins to repress TGFbeta signaling. , 1999, Genes & development.

[111]  S. Maity,et al.  Stable Expression of a Dominant Negative Mutant of CCAAT Binding Factor/NF-Y in Mouse Fibroblast Cells Resulting in Retardation of Cell Growth and Inhibition of Transcription of Various Cellular Genes* , 2000, The Journal of Biological Chemistry.

[112]  D. Hartmann,et al.  Comparative effects of interleukin-1 and tumor necrosis factor-alpha on collagen production and corresponding procollagen mRNA levels in human dermal fibroblasts. , 1991, The Journal of investigative dermatology.

[113]  J. Uitto,et al.  Nuclear Factor-κB Mediates TNF-α Inhibitory Effect on α2(I) Collagen (COL1A2) Gene Transcription in Human Dermal Fibroblasts , 1999, The Journal of Immunology.

[114]  P. Bornstein,et al.  Elements in the first intron of the alpha 1(I) collagen gene interact with Sp1 to regulate gene expression. , 1992, Gene expression.

[115]  R. Widom Regulation of matrix biosynthesis and degradation in systemic sclerosis , 2000, Current opinion in rheumatology.

[116]  R. Goodman,et al.  CREB-binding Protein and p300 in Transcriptional Regulation* , 2001, The Journal of Biological Chemistry.

[117]  M. Parker,et al.  Transcriptional repression of the α1(I) collagen gene by ras is mediated in part by an intronic AP1 site , 1995, Journal of cellular biochemistry.

[118]  K. Kivirikko,et al.  Collagens and collagen-related diseases , 2001, Annals of medicine.

[119]  D. Brenner,et al.  Sp1 binding activity increases in activated Ito cells , 1995, Hepatology.

[120]  G. Karsenty,et al.  Point mutations and small substitution mutations in three different upstream elements inhibit the activity of the mouse alpha 2(I) collagen promoter. , 1988, The Journal of biological chemistry.

[121]  A. Fine,et al.  Phorbol ester-induced inhibition of collagen accumulation by human lung fibroblasts. , 1990, The Journal of biological chemistry.

[122]  P. Dijke,et al.  Constitutive phosphorylation and nuclear localization of Smad3 are correlated with increased collagen gene transcription in activated hepatic stellate cells , 2001, Journal of cellular physiology.

[123]  C. Heldin,et al.  Identification of Smad7, a TGFβ-inducible antagonist of TGF-β signalling , 1997, Nature.

[124]  M. Bernard,et al.  DNA sequences in the first intron of the human pro-alpha 1(I) collagen gene enhance transcription. , 1987, The Journal of biological chemistry.

[125]  M. Ehrlich,et al.  A Methylation-responsive MDBP/RFX Site Is in the First Exon of the Collagen α2(I) Promoter* , 1999, The Journal of Biological Chemistry.

[126]  P. Bornstein,et al.  Structural and functional analysis of the first intron of the human alpha 2(I) collagen-encoding gene. , 1990, Gene.

[127]  C. Schindler Cytokines and JAK-STAT signaling. , 1999, Experimental cell research.

[128]  J. Uitto,et al.  An AP-1 Binding Sequence Is Essential for Regulation of the Human 2(I) Collagen (COL1A2) Promoter Activity by Transforming Growth Factor- (*) , 1996, The Journal of Biological Chemistry.

[129]  H. Ihn,et al.  Increased Expression of TGF-β Receptors by Scleroderma Fibroblasts: Evidence for Contribution of Autocrine TGF-β Signaling to Scleroderma Phenotype , 1998 .

[130]  E. Vuorio,et al.  Elevated proα2(I) collagen mRNA levels in cultured scleroderma fibroblasts result from an increased transcription rate of the corresponding gene , 1987, FEBS letters.

[131]  D. Pennington,et al.  Autocrine overexpression of CTGF maintains fibrosis: RDA analysis of fibrosis genes in systemic sclerosis. , 2000, Experimental cell research.

[132]  A. Roberts TGF-β signaling from receptors to the nucleus , 1999 .

[133]  D. Watson,et al.  Fli-1 Inhibits Collagen Type I Production in Dermal Fibroblasts via an Sp1-dependent Pathway* , 2001, The Journal of Biological Chemistry.

[134]  G. Sonenshein,et al.  B-Myb Expression in Vascular Smooth Muscle Cells Occurs in a Cell Cycle-dependent Fashion and Down-regulates Promoter Activity of Type I Collagen Genes (*) , 1996, The Journal of Biological Chemistry.

[135]  G. Karsenty,et al.  Tissue-specific expression of the mouse alpha 2(I) collagen promoter. Studies in transgenic mice and in tissue culture cells. , 1992, The Journal of biological chemistry.

[136]  C. Heldin,et al.  Phosphorylation of Smad7 at Ser-249 Does Not Interfere with Its Inhibitory Role in Transforming Growth Factor-β-dependent Signaling but Affects Smad7-dependent Transcriptional Activation* , 2001, The Journal of Biological Chemistry.

[137]  G. Karsenty,et al.  Tissue-specific expression of the mouse α2(I) collagen promoter : studies in transgenic mice and in tissue culture cells , 1992 .

[138]  Qingjian Wang,et al.  Okadaic acid-induced transcriptional downregulation of type I collagen gene expression is mediated by protein phosphatase 2A , 1979, Molecular and Cellular Biochemistry.

[139]  B. de Crombrugghe,et al.  Two different negative and one positive regulatory factors interact with a short promoter segment of the alpha 1 (I) collagen gene. , 1990, The Journal of biological chemistry.

[140]  J. Eisman,et al.  Ski-interacting Protein Interacts with Smad Proteins to Augment Transforming Growth Factor-β-dependent Transcription* , 2001, The Journal of Biological Chemistry.

[141]  Y. Inagaki,et al.  Transforming growth factor-beta stimulates alpha 2(I) collagen gene expression through a cis-acting element that contains an Sp1-binding site. , 1994, The Journal of biological chemistry.

[142]  J. Rossert,et al.  Regulation of type I collagen genes expression. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[143]  K. Luo,et al.  Negative Feedback Regulation of TGF-β Signaling by the SnoN Oncoprotein , 1999 .

[144]  B. de Crombrugghe,et al.  Transcriptional suppression of cellular gene expression by c-Myc , 1991, Molecular and cellular biology.

[145]  I. Weiß,et al.  Increased procollagen mRNA levels in scleroderma skin fibroblasts. , 1983, The Journal of investigative dermatology.

[146]  S. Tabibzadeh,et al.  Lefty Inhibits Receptor-regulated Smad Phosphorylation Induced by the Activated Transforming Growth Factor-β Receptor* , 2001, The Journal of Biological Chemistry.

[147]  A. Olsen,et al.  Interferon-gamma reverses the stimulation of collagen but not fibronectin gene expression by transforming growth factor-beta in normal human fibroblasts. , 1990, European journal of clinical investigation.

[148]  R. Derynck,et al.  The Type II Transforming Growth Factor (TGF)-β Receptor-interacting Protein TRIP-1 Acts as a Modulator of the TGF-β Response* , 1998, The Journal of Biological Chemistry.

[149]  M. Whitman Signal transduction: Feedback from inhibitory SMADs , 1997, Nature.

[150]  O. Eickelberg,et al.  Molecular mechanisms of TGF‐β antagonism by interferon γ and cyclosporine A in lung fibroblasts , 2001 .

[151]  J. Korn,et al.  Cloning and characterization of hcKrox, a transcriptional regulator of extracellular matrix gene expression. , 1997, Gene.

[152]  A. Olsen,et al.  Interferon‐γ reverses the stimulation of collagen but not fibronectin gene expression by transforming growth factor‐ β in normal human fibroblasts , 1990 .

[153]  J. Varga,et al.  Negative modulation of α1(I) procollagen gene expression in human skin fibroblasts: Transcriptional inhibition by interferon‐γ , 1999 .

[154]  S. Silbiger,et al.  Estradiol suppresses type I collagen synthesis in mesangial cells via activation of activator protein-1. , 1999, Kidney international.